313 related articles for article (PubMed ID: 27488585)
1. A Review on Pharmacological Properties of Coumarins.
Srikrishna D; Godugu C; Dubey PK
Mini Rev Med Chem; 2018; 18(2):113-141. PubMed ID: 27488585
[TBL] [Abstract][Full Text] [Related]
2. Coumarin hybrids as novel therapeutic agents.
Sandhu S; Bansal Y; Silakari O; Bansal G
Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Patil PO; Bari SB; Firke SD; Deshmukh PK; Donda ST; Patil DA
Bioorg Med Chem; 2013 May; 21(9):2434-50. PubMed ID: 23517722
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
[TBL] [Abstract][Full Text] [Related]
5. Chemistry and biological activity of natural and synthetic prenyloxycoumarins.
Curini M; Cravotto G; Epifano F; Giannone G
Curr Med Chem; 2006; 13(2):199-222. PubMed ID: 16472213
[TBL] [Abstract][Full Text] [Related]
6. Coumarins: Auspicious Cholinesterase and Monoamine Oxidase Inhibitors.
Orhan IE; Gulcan HO
Curr Top Med Chem; 2015; 15(17):1673-82. PubMed ID: 25915613
[TBL] [Abstract][Full Text] [Related]
7. A review of coumarin derivatives in pharmacotherapy of breast cancer.
Musa MA; Cooperwood JS; Khan MO
Curr Med Chem; 2008; 15(26):2664-79. PubMed ID: 18991629
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and selective human monoamine oxidase inhibition of 3-carbonyl, 3-acyl, and 3-carboxyhydrazido coumarin derivatives.
Secci D; Carradori S; Bolasco A; Chimenti P; Yáñez M; Ortuso F; Alcaro S
Eur J Med Chem; 2011 Oct; 46(10):4846-52. PubMed ID: 21872365
[TBL] [Abstract][Full Text] [Related]
9. MAO inhibitory activity modulation: 3-Phenylcoumarins versus 3-benzoylcoumarins.
Matos MJ; Vazquez-Rodriguez S; Uriarte E; Santana L; Viña D
Bioorg Med Chem Lett; 2011 Jul; 21(14):4224-7. PubMed ID: 21684743
[TBL] [Abstract][Full Text] [Related]
10. Benzocoumarins: isolation, synthesis, and biological activities.
Lv HN; Tu PF; Jiang Y
Mini Rev Med Chem; 2014; 14(7):603-22. PubMed ID: 24958219
[TBL] [Abstract][Full Text] [Related]
11. A review on biological activities and chemical synthesis of hydrazide derivatives.
Narang R; Narasimhan B; Sharma S
Curr Med Chem; 2012; 19(4):569-612. PubMed ID: 22204327
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a novel class of potent coumarin monoamine oxidase B inhibitors: development and biopharmacological profiling of 7-[(3-chlorobenzyl)oxy]-4-[(methylamino)methyl]-2H-chromen-2-one methanesulfonate (NW-1772) as a highly potent, selective, reversible, and orally active monoamine oxidase B inhibitor.
Pisani L; Muncipinto G; Miscioscia TF; Nicolotti O; Leonetti F; Catto M; Caccia C; Salvati P; Soto-Otero R; Mendez-Alvarez E; Passeleu C; Carotti A
J Med Chem; 2009 Nov; 52(21):6685-706. PubMed ID: 19810674
[TBL] [Abstract][Full Text] [Related]
13. Alkynyl-coumarinyl ethers as MAO-B inhibitors.
Mertens MD; Hinz S; Müller CE; Gütschow M
Bioorg Med Chem; 2014 Mar; 22(6):1916-28. PubMed ID: 24560738
[TBL] [Abstract][Full Text] [Related]
14. Pyrazolines: a biological review.
Marella A; Ali MR; Alam MT; Saha R; Tanwar O; Akhter M; Shaquiquzzaman M; Alam MM
Mini Rev Med Chem; 2013 May; 13(6):921-31. PubMed ID: 23544604
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of coumarin derivatives as inhibitors of Mycobacterium bovis (BCG).
Rezayan AH; Azerang P; Sardari S; Sarvary A
Chem Biol Drug Des; 2012 Dec; 80(6):929-36. PubMed ID: 22943459
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, human monoamine oxidase inhibitory activity and molecular docking studies of 3-heteroarylcoumarin derivatives.
Delogu G; Picciau C; Ferino G; Quezada E; Podda G; Uriarte E; Viña D
Eur J Med Chem; 2011 Apr; 46(4):1147-52. PubMed ID: 21316817
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in coumarins and 1-azacoumarins as versatile biodynamic agents.
Kulkarni MV; Kulkarni GM; Lin CH; Sun CM
Curr Med Chem; 2006; 13(23):2795-818. PubMed ID: 17073630
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into monoamine oxidase inhibitory potency and selectivity of 7-substituted coumarins from ligand- and target-based approaches.
Catto M; Nicolotti O; Leonetti F; Carotti A; Favia AD; Soto-Otero R; Méndez-Alvarez E; Carotti A
J Med Chem; 2006 Aug; 49(16):4912-25. PubMed ID: 16884303
[TBL] [Abstract][Full Text] [Related]
19. A new series of 3-phenylcoumarins as potent and selective MAO-B inhibitors.
Matos MJ; Viña D; Quezada E; Picciau C; Delogu G; Orallo F; Santana L; Uriarte E
Bioorg Med Chem Lett; 2009 Jun; 19(12):3268-70. PubMed ID: 19423346
[TBL] [Abstract][Full Text] [Related]
20. Natural and synthetic coumarin derivatives with anti-inflammatory/ antioxidant activities.
Fylaktakidou KC; Hadjipavlou-Litina DJ; Litinas KE; Nicolaides DN
Curr Pharm Des; 2004; 10(30):3813-33. PubMed ID: 15579073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
